GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (STU:BVF) » Definitions » Cyclically Adjusted PB Ratio

Bausch Health (STU:BVF) Cyclically Adjusted PB Ratio : 0.80 (As of May. 22, 2024)


View and export this data going back to . Start your Free Trial

What is Bausch Health Cyclically Adjusted PB Ratio?

As of today (2024-05-22), Bausch Health's current share price is €5.98. Bausch Health's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €7.52. Bausch Health's Cyclically Adjusted PB Ratio for today is 0.80.

The historical rank and industry rank for Bausch Health's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:BVF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.41   Med: 1.92   Max: 25.21
Current: 0.81

During the past years, Bausch Health's highest Cyclically Adjusted PB Ratio was 25.21. The lowest was 0.41. And the median was 1.92.

STU:BVF's Cyclically Adjusted PB Ratio is ranked better than
76.21% of 681 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs STU:BVF: 0.81

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bausch Health's adjusted book value per share data for the three months ended in Mar. 2024 was €-2.798. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €7.52 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bausch Health Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bausch Health's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Cyclically Adjusted PB Ratio Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.35 1.72 2.45 0.63 0.92

Bausch Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.84 0.92 0.92 1.31

Competitive Comparison of Bausch Health's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted PB Ratio falls into.



Bausch Health Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bausch Health's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.98/7.52
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bausch Health's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-2.798/126.2576*126.2576
=-2.798

Current CPI (Mar. 2024) = 126.2576.

Bausch Health Quarterly Data

Book Value per Share CPI Adj_Book
201406 11.594 99.473 14.716
201409 11.902 99.394 15.119
201412 12.804 98.367 16.434
201503 17.419 99.789 22.039
201506 16.728 100.500 21.015
201509 16.471 100.421 20.709
201512 15.821 99.947 19.986
201603 14.806 101.054 18.499
201606 13.740 102.002 17.007
201609 10.680 101.765 13.250
201612 8.591 101.449 10.692
201703 10.464 102.634 12.873
201706 10.039 103.029 12.302
201709 12.821 103.345 15.664
201712 14.173 103.345 17.315
201803 10.274 105.004 12.354
201806 8.489 105.557 10.154
201809 7.726 105.636 9.234
201812 6.866 105.399 8.225
201903 6.773 106.979 7.994
201906 6.535 107.690 7.662
201909 6.395 107.611 7.503
201912 2.714 107.769 3.180
202003 1.835 107.927 2.147
202006 1.186 108.401 1.381
202009 1.404 108.164 1.639
202012 1.237 108.559 1.439
202103 -0.462 110.298 -0.529
202106 -1.590 111.720 -1.797
202109 -0.483 112.905 -0.540
202112 -0.261 113.774 -0.290
202203 -0.543 117.646 -0.583
202206 -1.813 120.806 -1.895
202209 -1.466 120.648 -1.534
202212 -1.805 120.964 -1.884
202303 -2.055 122.702 -2.115
202306 -1.681 124.203 -1.709
202309 -3.029 125.230 -3.054
202312 -2.566 125.072 -2.590
202403 -2.798 126.258 -2.798

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bausch Health  (STU:BVF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bausch Health Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bausch Health's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (STU:BVF) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (STU:BVF) Headlines

No Headlines